The Ulcerative Colitis Market is seeing remission maintenance drive ulcerative colitis treatment demand significantly where ulcerative colitis patients require long-term remission maintenance therapy improving remission rates by 75%, reducing disease flares by 80%, and enabling sustained symptom control for 5+ years creating substantial ulcerative colitis treatment demand. Remission...